Winter may be coming but biotech winter is thawing

Tips for communicators from the Fierce Biotech Summit 2024 Colder weather is coming, but biotech’s winter is actually heating up. You could hear the excitement for the upturn as leaders shared their insights at last week’s #FierceBiotechSummit in an unseasonably warm Boston. While the numbers don’t match the sentiment, with Q3 numbers tracking much like […]
Industry Leaders Gather to Elevate NYC as Premier Location for Medical Innovation

Cure® and Makovsky Co-Host a Dialogue on Accelerating NYC’s Growth as a Life Sciences Powerhouse NEW YORK, Nov. 2, 2023 /PRNewswire/ — Cure, a healthcare innovation campus, in partnership with Makovsky, a leading independent communications consultancy, will bring together New York City (“NYC”) civic and life science leaders for the first in a series of discussions about how the local life sciences ecosystem […]
Investment for Biotech Innovation is Shrinking: Biotechs Need a PR Playbook To Encourage an IRA Modification

The IRA’s healthcare pricing rules reflect good intentions but faulty logic, leading to long-term harm for many categories of patients, especially those with rare diseases. Biotech innovators need to help official decision-makers better understand how the Inflation Reduction Act’s (IRA) drug pricing requirements are already deterring investment in future medical innovation and help correct this […]
Communication Insights: The IRA and A Still Cautious Biotech Investor Environment

With a year into the IRA, we are continuing to see the adverse impact on investment in innovation around key drugs, especially small molecules. At the recent 18th annual Fierce Pharma PR & Communications Summit in New Jersey, conversations centered around adapting communications to investors made increasingly risk averse given IRA’s limitations on long term […]